SMED
Undervalued by 18.6% based on the discounted cash flow analysis.
Market cap | $0.00 |
---|---|
Enterprise Value | $-5,539,000.00 |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.76 |
Beta | 1.28 |
Outstanding Shares | 19,412,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 11.58 |
---|---|
PEG | -11.27 |
Price to Sales | 2.92 |
Price to Book Ratio | 2.92 |
Enterprise Value to Revenue | -0.08 |
Enterprise Value to EBIT | -1.05 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | -3.83 |
Debt to Equity | 0.33 |
No data
No data